Patient disease trajectories in rheumatoid arthritis patients treated with baricitinib 4-mg in 4 phase 3 clinical studies by Taylor, PC, Chen, YF, Pope, J, Weinblatt, M, Mysler, E, Rubbert-Roth, A, Jia, B, Sun, L, Liu, Y, Holzkämper, T, Tanaka, Y

Patient disease trajectories in baricitinib-treated patients with rheumatoid arthritis and inadequate response to methotrexate by Taylor, P, Emery, P, Weinblatt, M, Mysler, E, Rubbert-Roth, A, Jia, B, Sun, L, Liu, Y, Chen, Y, Cardoso, A, Tanaka, Y

“Evolving the management of RA” programme: educational tools to support daily practice by Burmester, G, Alvaro-Gracia, JM, Betteridge, N, Calvo-Alen, J, Combe, B, Durez, P, Ferreira, RJO, Fautrel, B, Iagnocco, A, Montecucco, C, Østergaard, M, Ramiro, S, Rubbert-Roth, A, Stamm, T, Szekanecz, Z, Taylor, PC, van de Laar, M

Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools by Burmester, GR, Álvaro-Gracia, JM, Betteridge, N, Calvo Alén, J, Combe, B, Durez, P, Fautrel, B, Ferreira, RJO, Gabay, C, Iagnocco, A, Montecucco, C, Østergaard, M, Ramiro, S, Rubbert-Roth, A, Stamm, T, Szekanecz, Z, Taylor, PC, Van de Laar, M

Evolving the management of rheumatoid arthritis (eRA) through development of practical and educational tools by Van De Laar, M, Álvaro-Gracia, J, Betteridge, N, Calvo Alén, J, Combe, B, Durez, P, Ferreira, R, Fautrel, B, Gabay, C, Iagnocco, A, Montecucco, C, Østergaard, M, Ramiro, S, Rubbert-Roth, A, Stamm, T, Szekanecz, Z, Taylor, P, Burmester, G

Efficacy and safety of baricitinib versus placebo and adalimumab in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate: Summar... by Taylor, P, Krogulec, M, Dudek, A, Dudler, J, Drescher, E, Cseuz, R, Kausiene, R, Andersone, D, Unikiene, D, Sanchez Burson, J, Blanco Alonso, R, Dvorak, Z, Ghizdavescu, A, Irto, I, Larsson, E, Bello, N, Barry, J, Durand, F, Holzkaemper, T, Otawa, S, De Bono, S, Keystone, E, Rubbert-Roth, A, Combe, B, De La Torre, I

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update by Smolen, J, Landewé, R, Bijlsma, J, Burmester, G, Chatzidionysiou, K, Dougados, M, Nam, J, Ramiro, S, Voshaar, M, van Vollenhoven, R, Aletaha, D, Aringer, M, Boers, M, Buckley, C, Buttgereit, F, Bykerk, V, Cardiel, M, Combe, B, Cutolo, M, van Eijk-Hustings, Y, Emery, P, Finckh, A, Gabay, C, Gomez-Reino, J, Gossec, L, Gottenberg, J, Hazes, J, Huizinga, T, Jani, M, Karateev, D, Kouloumas, M, Kvien, T, Li, Z, Mariette, X, McInnes, I, Mysler, E, Nash, P, Pavelka, K, Poór, G, Richez, C, van Riel, P, Rubbert-Roth, A, Saag, K, da Silva, J, Stamm, T, Takeuchi, T, Westhovens, R, de Wit, M, van der Heijde, D